Skip to main content

Advertisement

Log in

Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Background

Ayahuasca is a psychotropic plant tea used for ritual purposes by the indigenous populations of the Amazon. In the last two decades, its use has expanded worldwide. The tea contains the psychedelic 5-HT2A receptor agonist N,N-dimethyltryptamine (DMT), plus β-carboline alkaloids with monoamine-oxidase-inhibiting properties. Acute administration induces an introspective dream-like experience characterized by visions and autobiographic and emotional memories. Studies of long-term users have suggested its therapeutic potential, reporting that its use has helped individuals abandon the consumption of addictive drugs. Furthermore, recent open-label studies in patients with treatment-resistant depression found that a single ayahuasca dose induced a rapid antidepressant effect that was maintained weeks after administration. Here, we conducted an exploratory study of the psychological mechanisms that could underlie the beneficial effects of ayahuasca.

Methods

We assessed a group of 25 individuals before and 24 h after an ayahuasca session using two instruments designed to measure mindfulness capacities: The Five Facets Mindfulness Questionnaire (FFMQ) and the Experiences Questionnaire (EQ).

Results

Ayahuasca intake led to significant increases in two facets of the FFMQ indicating a reduction in judgmental processing of experiences and in inner reactivity. It also led to a significant increase in decentering ability as measured by the EQ. These changes are classic goals of conventional mindfulness training, and the scores obtained are in the range of those observed after extensive mindfulness practice.

Conclusions

The present findings support the claim that ayahuasca has therapeutic potential and suggest that this potential is due to an increase in mindfulness capacities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Baer RA, Smith GT, Hopkins J et al (2006) Using self-report assessment methods to explore facets of mindfulness. Assessment 13:27–45

    Article  PubMed  Google Scholar 

  • Bishop SR, Lau M, Shapiro S et al (2004) Mindfulness: a proposed operational definition. Clin Psychol Sci Pract 11:230–241

    Article  Google Scholar 

  • Bliss S, McCardle M (2013) An exploration of common elements in dialectical behavior therapy, mentalization based treatment and transference focused psychotherapy in the treatment of borderline personality disorder. Clin Soc Work J 42:61–69

    Article  Google Scholar 

  • Bouso JC, González D, Fondevila S et al (2012) Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study. PLoS One 7:e42421

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Bouso JC, Palhano-Fontes F, Rodríguez-Fornells A et al (2015) Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans. Eur Neuropsychopharmacol 25:483–492

    Article  CAS  PubMed  Google Scholar 

  • Brown KW, Ryan RM (2003) The benefits of being present: mindfulness and its role in psychological well-being. J Pers Soc Psychol 84:822–848

    Article  PubMed  Google Scholar 

  • Buckholtz NS, Boggan WO (1977a) Monoamine oxidase inhibition in brain and liver produced by beta-carbolines: structure-activity relationships and substrate specificity. Biochem Pharmacol 26:1991–1996

    Article  CAS  PubMed  Google Scholar 

  • Buckholtz NS, Boggan WO (1977b) Inhibition by beta-carbolines of monoamine uptake into a synaptosomal preparation: structure-activity relationships. Life Sci 20:2093–2099

    Article  CAS  PubMed  Google Scholar 

  • Carmody J, Baer RA, Lykins ELB, Olendzki N (2009) An empirical study of the mechanisms of mindfulness in a mindfulness-based stress reduction program. J Clin Psychol 65:613–626

    Article  PubMed  Google Scholar 

  • Cebolla A, Garcia Palacios A, Soler J et al (2012) Psychometric properties of the Spanish validation of the Five Facets of Mindfulness Questionnaire (FFMQ). Eur J Psychiatry 26:118–126.

    Article  Google Scholar 

  • Coffey KA, Hartman M, Fredrickson BL (2010) Deconstructing mindfulness and constructing mental health: understanding mindfulness and its mechanisms of action. Mindfulness 1:235–253

    Article  Google Scholar 

  • Fábregas JM, González D, Fondevila S et al (2010) Assessment of addiction severity among ritual users of ayahuasca. Drug Alcohol Depend 111:257–261

    Article  PubMed  Google Scholar 

  • Foa EB, Riggs DS, Massie ED, Yarczower M (1995) The impact of fear activation and anger on the efficacy of exposure treatment for posttraumatic stress disorder. Behav Ther 26:487–499

    Article  Google Scholar 

  • Fontanilla D, Johannessen M, Hajipour AR et al (2009) The hallucinogen N, N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science 323:934–937

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Fresco DM, Moore MT, van Dulmen MHM et al (2007a) Initial psychometric properties of the experiences questionnaire: validation of a self-report measure of decentering. Behav Ther 38:234–246

    Article  PubMed  Google Scholar 

  • Fresco DM, Segal ZV, Buis T, Kennedy S (2007b) Relationship of posttreatment decentering and cognitive reactivity to relapse in major depression. J Consult Clin Psychol 75:447–455

    Article  PubMed  Google Scholar 

  • Frood A (2015) Ayahuasca psychedelic tested for depression. Nature. doi:10.1038/nature.2015.17252

    Google Scholar 

  • Gasser P, Holstein D, Michel Y et al (2014) Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. J Nerv Ment Dis 202:513–520

    Article  PubMed Central  PubMed  Google Scholar 

  • Grob CS, Danforth AL, Chopra GS et al (2011) Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry 68:71–78

    Article  CAS  PubMed  Google Scholar 

  • Grossman P (2008) On measuring mindfulness in psychosomatic and psychological research. J Psychosom Res 64:405–408

    Article  PubMed  Google Scholar 

  • Grossman P (2011) Defining mindfulness by how poorly I think I pay attention during everyday awareness and other intractable problems for psychology’s (re)invention of mindfulness: comment on Brown et al. (2011). Psychol Assess 23:1034–1040, discussion 1041–1046

    Article  PubMed  Google Scholar 

  • Hayes-skelton SA, Calloway A, Roemer L, Orsillo SM (2014) Decentering as a potential common mechanism across two therapies for generalized anxiety disorder. J Consult Clin Psychol 83:395–404

    Article  PubMed  Google Scholar 

  • Holzel BK, Lazar SW, Gard T et al (2011) How does mindfulness meditation work? Proposing mechanisms of action from a conceptual and neural perspective. Perspect Psychol Sci 6:537–559

    Article  PubMed  Google Scholar 

  • Kabat-Zinn J (1990) Full catastrophe living: using the wisdom of your body and mind to face stress, pain, and illness. Delacorte, New York

    Google Scholar 

  • Kraehenmann R, Preller KH, Scheidegger M et al (2014) Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers. Biol Psychiatry

  • Lilja JL, Lundh L-G, Josefsson T, Falkenström F (2012) Observing as an essential facet of mindfulness: a comparison of FFMQ patterns in meditating and non-meditating individuals. Mindfulness 4:203–212

    Article  Google Scholar 

  • McIlhenny EH, Pipkin KE, Standish LJ et al (2009) Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography-electrospray ionization-tandem mass spectrometry. J Chromatogr A 1216:8960–8968

    Article  CAS  PubMed  Google Scholar 

  • McKenna DJ, Towers GN, Abbott F (1984) Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and β-carboline constituents of ayahuasca. J Ethnopharmacol 10:195–223

    Article  CAS  PubMed  Google Scholar 

  • Osório F de L, Sanches RF, Macedo LR (2015) Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report. Rev Bras Psiquiatr São Paulo Braz 37:13–20

    Article  Google Scholar 

  • Pezawas L, Meyer-Lindenberg A, Drabant EM et al (2005) 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 8:828–834

    Article  CAS  PubMed  Google Scholar 

  • Raichle ME, MacLeod AM, Snyder AZ et al (2001) A default mode of brain function. Proc Natl Acad Sci U S A 98:676–682

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Riba J (2003) Human pharmacology of ayahuasca. Autonomous University of Barcelona

  • Riba J, Rodríguez-Fornells A, Urbano G et al (2001) Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers. Psychopharmacology (Berl) 154:85–95

    Article  CAS  Google Scholar 

  • Riba J, Romero S, Grasa E et al (2006) Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant. Psychopharmacology (Berl) 186:93–98

    Article  CAS  Google Scholar 

  • Riba J, McIlhenny EH, Bouso JC, Barker SA (2015) Metabolism and urinary disposition of N, N-dimethyltryptamine after oral and smoked administration: a comparative study. Drug Test Anal 7:401–406

    Article  CAS  PubMed  Google Scholar 

  • Rivier L, Lindgren JE (1972) “Ayahuasca”, the South American hallucinogenic drink: an ethnobotanical and chemical investigation. Econ Bot 26:101–129

    Article  CAS  Google Scholar 

  • Sanches RF, Osório FL, dos Santos RG et al (2015) Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study. J Clin Psychopharmacol in press

  • Santos RG, Landeira-Fernandez J, Strassman RJ et al (2007) Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members. J Ethnopharmacol 112:507–513

    Article  CAS  PubMed  Google Scholar 

  • Schultes RE (1980) The botany and chemistry of hallucinogens, Rev. and enl. 2d ed. Thomas, Springfield

  • Segal ZV, Kennedy S, Gemar M et al (2006) Cognitive reactivity to sad mood provocation and the prediction of depressive relapse. Arch Gen Psychiatry 63:749–755

    Article  PubMed  Google Scholar 

  • Sessa B, Johnson MW (2015) Can psychedelic compounds play a part in drug dependence therapy? Br J Psychiatry 206:1–3

    Article  PubMed  Google Scholar 

  • Shanon B (2002) The antipodes of the mind: charting the phenomenology of the Ayahuasca experience. Oxford University Press, Oxford

    Google Scholar 

  • Shapiro S, Carlson LE, Astin J, Freedman B (2006) Mechanisms of mindfulness. J Clin Psychol 62:373–386

    Article  PubMed  Google Scholar 

  • Sheline YI, Price JL, Yan Z, Mintun MA (2010) Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus. Proc Natl Acad Sci U S A 107:11020–11025

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Soler J, Cebolla A, Feliu-Soler A et al (2014a) Relationship between meditative practice and self-reported mindfulness: the MINDSENS composite index. PLoS ONE 9:e86622

    Article  PubMed Central  PubMed  Google Scholar 

  • Soler J, Franquesa A, Feliu-Soler A et al (2014b) Assesing decentering: validation, psychometric properities and clinical usefulness of the Experiences Questionnaire in a Spanish sample. Behav Ther 45:863–871

    Article  PubMed  Google Scholar 

  • Suzuki O, Katsumata Y, Oya M (1981) Characterization of eight biogenic indoleamines as substrates for type A and type B monoamine oxidase. Biochem Pharmacol 30:1353–1358

    Article  CAS  PubMed  Google Scholar 

  • Taylor A, Grant J, Breton E et al (2013) Impact of meditation training on the default mode network during a restful state. 4–14

  • Teasdale JD, Moore R, Hayhurst H et al (2002) Metacognitive awareness and prevention of relapse in depression: empirical evidence. J Consult Clin Psychol 70:275–287

    Article  PubMed  Google Scholar 

  • Tejedor R, Feliu-Soler A, Pascual JC et al (2014) Propiedades psicométricas de la versión española de la Philadelphia Mindfulness Scale. Rev Psiquiatr Salud Ment 7:157–165

    Article  PubMed  Google Scholar 

  • Thomas G, Lucas P, Capler NR et al (2013) Ayahuasca-assisted therapy for addiction: results from a preliminary observational study in Canada. Curr Drug Abuse Rev 6:30–42

    Article  PubMed  Google Scholar 

  • Tupper KW (2008) The globalization of ayahuasca: harm reduction or benefit maximization? Int J Drug Policy 19:297–303

    Article  PubMed  Google Scholar 

  • Veehof MM, Peter M, Taal E et al (2011) Psychometric properties of the Dutch Five Facet Mindfulness Questionnaire (FFMQ) in patients with fibromyalgia. Clin Rheumatol 30:1045–1054

    Article  PubMed Central  PubMed  Google Scholar 

  • Vollenweider FX, Kometer M (2010) The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nat Rev Neurosci 11:642–651

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors wish to thanks the volunteers for their participation.

Contributors

Jordi Riba, Amanda Feilding, Pablo Friedlander, and Joaquim Soler conceived and designed the study. Steven Barker analyzed the ayahuasca and Jordi Riba and Alba Franquesa collected the data. Matilde Elices and Juan Carlos Pascual performed the statistical analyses and wrote the first version of the manuscript. All authors contributed to the final version of this manuscript and approved it.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jordi Riba.

Ethics declarations

The study was conducted in accordance with the Declaration of Helsinki and subsequent amendments concerning research in humans and was approved by the Sant Pau Hospital Ethics Committee. All volunteers gave their written informed consent to participate.

Conflict of interest

The authors declare that they have no competing interests.

Funding

This study was supported by the Beckley Foundation.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Soler, J., Elices, M., Franquesa, A. et al. Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities. Psychopharmacology 233, 823–829 (2016). https://doi.org/10.1007/s00213-015-4162-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-015-4162-0

Keywords

Navigation